DiaMedica Therapeutics Inc.

DMAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $1.4M
Accounts Receivable $80.0K
Inventory —
Total Current Assets $1.5M
Property, Plant & Equipment $37.0K
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $1.8M
Liabilities
Accounts Payable $513.0K
Total Current Liabilities $1.0M
Long-Term Debt —
Total Liabilities $1.0M
Stockholders' Equity
Retained Earnings $-40.2M
Total Stockholders' Equity $799.0K
← Newer Page 2 of 2 Older →